Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

Yang, Wei‐Shiung; Jeng, Chi-Yuan; Wu, Ta-Jen; Tanaka, Sachiyo; Funahashi, Tohru; Matsuzawa, Yūji; Wang, Jao-Ping; Chen, Chi‐Ling; Tai, Tong‐Yuan; Chuang, Lee‐Ming

doi:10.2337/diacare.25.2.376

Public

Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

Published in Diabetes Care • Feb 1, 2002

Authors:

Wei‐Shiung Yang

Chi-Yuan Jeng

Ta-Jen Wu

Abstract

OBJECTIVE: Adiponectin, a plasma protein exclusively synthesized and secreted by adipose tissue, has recently been shown to have anti-inflammatory, antiatherogenic properties in vitro and beneficial metabolic effects in animals. Lower plasma levels of adiponectin have been documented in human subjec...

Subject

Rosiglitazone

Adiponectin

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!